Stephen Kent retweeted
Research Highlight rdcu.be/c8pFw on a paper by Juno and colleagues that examines T cells frequency and phenotype after Delta and Omicron breakthrough infection in previously vaccinated individuals.
Stephen Kent retweeted
Our latest preprint shows that neutralising antibodies predict protection from severe COVID-19. Great collaborating with @ProfStephenKent @m_steain on this important work from the @KirbyInstitute medrxiv.org/content/10.1101/…
Stephen Kent retweeted
On paper on immune dysfunction during #longCOVID
is now publish @NatImmunol.
@DavidDarley_ @Dan_B_Wilson @GregDore2 @KirbyInstitute @KentLaboratory @TheDohertyInst
nature.com/articles/s41590-0…
Stephen Kent retweeted
Really pleased to share our review on the potential risks of antibody-dependent enhancement (ADE) in #SARSCoV2 infection. We also highlight risk mitigation strategies for vaccination and therapeutic antibody interventions. nature.com/articles/s41564-0… @WheatleyAtotheK @KentLaboratory
Stephen Kent retweeted
1. New work from us (@WheatleyAtotheK @scientist_JJ @WenShiLee @KentLaboratory @TheDohertyInst) comparing whole S or the smaller RBD of #SARSCoV2 as #vaccines. We asked what would homologous/heterologous prime-boost vaccinations look like in mice/monkeys. Cont.
#COVID19
Prime-boost protein subunit vaccines against SARS-CoV-2 are highly immunogenic in mice and macaques biorxiv.org/cgi/content/shor… #bioRxiv
Stephen Kent retweeted
Thanks Alex for making such a beautiful Cover for our joint paper with @KentLaboratory and other co-workers at CBNS @ARCCoEBionano. Everyone can check out Alex’s professional work here: alexkakinenstudio.com/ and our paper here: onlinelibrary.wiley.com/doi/…
ALT https://onlinelibrary.wiley.com/doi/10.1002/smll.202070185
Stephen Kent retweeted
Our most recent study: tetramer staining of healthy donors and #COVID19 patients show a suboptimal #SARSCoV2 specific CD8 T-cell response associated with the prominent HLA-A*02:01 phenotype. doi.org/10.1101/2020.08.17.2… Fantastic teamwork @kedzierskalab @TheDohertyInst
Stephen Kent retweeted
Tune in for #20phds20mins at 11am this Sunday to hear all about our Phd's in just 60 seconds!
The 30th Anniversary Edition #20phds20mins participants have now been selected. A huge thank you to the very large number of people who applied. You will hear them all on @einstein_agogo this Sunday from 11am on @3RRRFM
Stephen Kent retweeted
Handy lit review from @Hyonxhi, one of @KentLaboratory's excellent B cell experts!
Stephen Kent retweeted
Congratulations to Dr Jennifer Juno and colleagues, whose research on the immune response to #COVID-19’s spike protein has been published in Nature Medicine tonight – information that's important for future validation of vaccine candidates.
doherty.edu.au/news-events/n…
Stephen Kent retweeted
Really pleased to share our study of antibody, B cell and cTfh responses toward SARS-CoV-2 spike protein in convalescent donors, now out in @NatureMedicine! Stellar team effort from @Hyonxhi, @WheatleyAtotheK and @KentLaboratory.
nature.com/articles/s41591-0…
Stephen Kent retweeted
So happy to share our work just published in Small: doi.org/10.1002/smll.2020028…
Many thanks to Tom, the Kent Lab @KentLaboratory and other co-workers at CBNS @ARCCoEBionano.
Also thanks to Athina @AthinaAnastasa1 at ETH Polymeric Materials @AnastasakiLab for useful discussions.
ALT https://onlinelibrary.wiley.com/journal/16136829
Stephen Kent retweeted
If you need a break from COVID-related papers, check out our latest work in @CellReports, where we describe an IL-23 responsive subset of human Vd2 T cells.
cell.com/cell-reports/fullte…
Defined by high CD26 expression, these cells are present in adults and neonates...
Stephen Kent retweeted
This MRFF #antiviral #COVID19 bid was only possible with the generous transparent sharing of reagents, data, assays, I am so excited to be working with these incredible #antibody partners @TheDohertyInst @BurnetInstitute @CSL @UNSW @CSIRO Affinity Bio
Stephen Kent retweeted
Never had a lava lamp, but happy to make do with these killer lymph node shots. New paper from our PhD student Hannah in @KentLaboratory out today in @JCI_insight
Stephen Kent retweeted
Next in our Trending Virtual Issue: Hillary Vanderven @KentLaboratory breaks down the protective potential of Fc‐mediated antibody functions against #influenza virus and other viral pathogens. #ICBnews #RespiratoryViruses onlinelibrary.wiley.com/doi/…
Stephen Kent retweeted
Targeting cancer with peptide functionalised non-spherical polymersome! Congrats @KristelTjandra @chinkenwong & Chelsea Forest. Big thanks to all our collaborators: @ARCCoEBionano @NanoMed_UNSW @KidsCancerInst @MK_CCI @CAMD_Stenzel @KentLaboratory #ozchem #chemistry @UNSWScience
I’m delighted to share the publication of part of my doctorate work with @PalliThordarson @NanoMed_UNSW a fruitful collaboration with multiple @ARCCoEBionano research groups! Huge thanks to those involved! 🥂onlinelibrary.wiley.com/doi/… #nanomedicine #nanoparticle #drugdelivery
Stephen Kent retweeted
1/ Excited to share @kentlaboratory's first pre-print! With @Hyonxhi and @WheatleyAtotheK, we characterised the B and T cell response to #SARS-CoV-2 spike in 41 convalescent adults. Great collaboration cross the @TheDohertyInst @WEHI_research @WHOCCFluMelb. What did we find?
Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19 medrxiv.org/cgi/content/shor… #medRxiv
Stephen Kent retweeted
Our editor's pick for the month is from Hillary Vanderven @KentLaboratory. They explore the use of antibodies with Fc‐mediated effector functions to prevent and control viral infections, especially #influenza.
#ICBnews @TheDohertyInst
onlinelibrary.wiley.com/doi/…
Stephen Kent retweeted
When you think of IgA you probably think of mucosal IgA. However, IgA is the second most common antibody in the blood, with important and mysterious roles in disease🦠. Check out my short review to learn more!! @KentLaboratory @DohertyStudents @AmyWChung onlinelibrary.wiley.com/doi/…
